Inactivation of Mst/Nrf2/Keap1 signaling flexibly mitigates MAPK/NQO-HO1 activation in the reproductive axis of experimental fluorosis

Fluoride induced reprotoxicity through oxidative stress-mediated reproductive cell death. Hence, the current study evaluated the importance of the MST/Nrf2/MAPK/NQO-HO1 signaling pathway in fluorosis-induced reproductive toxicity. For this purpose, the reproductive toxicity of sodium fluoride (NaF) at physiological, biochemical, and intracellular levels was evaluated. In-vivo, NaF at 100 mg/L instigated physiological dysfunction, morphological, stereological, and structural injuries in the gut-gonadal axis of fluorosis mice through weakening the antioxidant signaling, Nrf2/HO-1/NQO1signaling pathway, causing the gut-gonadal barrier disintegrated via oxidative stress-induced inflammation, mitochondrial damage, apoptosis, and autophagy. Similar trends were also observed in-vitro in the isolated Leydig cells (LCs) challenging with 20 mg/L NaF. Henceforth, activating the cellular antioxidant signaling pathway, Nrf2/HO-1/NQO1, inactivating autophagy and apoptosis, or attenuating lipopolysaccharide (LPS) can be the theoretical basis and valuable therapeutic targets for coping with NaF-induced reproductive toxicity.

Glycine protects the male reproductive system against lead toxicity via alleviating oxidative stress, preventing sperm mitochondrial impairment, improving kinematics of sperm, and blunting the downregulation of enzymes involved in the steroidogenesis

Lead (Pb) is a highly toxic heavy metal widely dispersed in the environment because of human industrial activities. Many studies revealed that Pb could adversely affect several organs, including the male reproductive system. Pb-induced reproductive toxicity could lead to infertility. Thus, finding safe and clinically applicable protective agents against this complication is important. It has been found that oxidative stress plays a fundamental role in the pathogenesis of Pb-induced reprotoxicity. Glycine is the simplest amino acid with a wide range of pharmacological activities. It has been found that glycine could attenuate oxidative stress and mitochondrial impairment in various experimental models. The current study was designed to evaluate the role of glycine in Pb-induced reproductive toxicity in male mice. Male BALB/c mice received Pb (20 mg/kg/day; gavage; 35 consecutive days) and treated with glycine (250 and 500 mg/kg/day; gavage; 35 consecutive days). Then, reproductive system weight indices, biomarkers of oxidative stress in the testis and isolated sperm, sperm kinetic, sperm mitochondrial indices, and testis histopathological alterations were monitored. A significant change in testis, epididymis, and Vas deferens weight was evident in Pb-treated animals. Markers of oxidative stress were also significantly increased in the testis and isolated sperm of the Pb-treated group. A significant disruption in sperm kinetic was also evident when mice received Pb. Moreover, Pb exposure caused significant deterioration in sperm mitochondrial indices. Tubular injury, tubular desquamation, and decreased spermatogenic index were histopathological alterations detected in Pb-treated mice. It was found that glycine significantly blunted oxidative stress markers in testis and sperm, improved sperm mitochondrial parameters, causing considerable higher velocity-related indices (VSL, VCL, and VAP) and percentages of progressively motile sperm, and decreased testis histopathological changes in Pb-exposed animals. These data suggest glycine as a potential protective agent against Pb-induced reproductive toxicity. The effects of glycine on oxidative stress markers and mitochondrial function play a key role in its protective mechanism.

The Role of Mitochondrial Impairment and Oxidative Stress in the Pathogenesis of Lithium-Induced Reproductive Toxicity in Male Mice

Lithium (Li+) is prescribed against a wide range of neurological disorders. Besides its excellent therapeutic properties, there are several adverse effects associated with Li+. The impact of Li+ on renal function and diabetes insipidus is the most common adverse effect of this drug. On the other hand, infertility and decreased libido is another complication associated with Li+. It has been found that sperm indices of functionality, as well as libido, is significantly reduced in Li+-treated men. These adverse effects might lead to drug incompliance and the cessation of drug therapy. Hence, the main aims of the current study were to illustrate the mechanisms of adverse effects of Li+ on the testis tissue, spermatogenesis process, and hormonal changes in two experimental models. In the in vitro experiments, Leydig cells (LCs) were isolated from healthy mice, cultured, and exposed to increasing concentrations of Li+ (0, 10, 50, and 100 ppm). In the in vivo section of the current study, mice were treated with Li+ (0, 10, 50, and 100 ppm, in drinking water) for five consecutive weeks. Testis and sperm samples were collected and assessed. A significant sign of cytotoxicity (LDH release and MTT assay), along with disrupted testosterone biosynthesis, impaired mitochondrial indices (ATP level and mitochondrial depolarization), and increased biomarkers of oxidative stress were detected in LCs exposed to Li+. On the other hand, a significant increase in serum and testis Li+ levels were detected in drug-treated mice. Moreover, ROS formation, LPO, protein carbonylation, and increased oxidized glutathione (GSSG) were detected in both testis tissue and sperm specimens of Li+-treated mice. Several sperm anomalies were also detected in Li+-treated animals. On the other hand, sperm mitochondrial indices (mitochondrial dehydrogenases activity and ATP levels) were significantly decreased in drug-treated groups where mitochondrial depolarization was increased dose-dependently. Altogether, these data mention oxidative stress and mitochondrial impairment as pivotal mechanisms involved in Li+-induced reproductive toxicity. Therefore, based on our previous publications in this area, therapeutic options, including compounds with high antioxidant properties that target these points might find a clinical value in ameliorating Li+-induced adverse effects on the male reproductive system.

Differential effects of rapid eye movement sleep deprivation and immobilization stress on blood lymphocyte subsets in rats

OBJECTIVES

There is growing evidence of the relationship between sleep and the immune response. Studies aimed at elucidating the function of rapid eye movement (REM) sleep have found it difficult to separate the effects due to REM sleep deprivation and the effects due to the stress produced by the deprivation procedure. It has been claimed that immobilization is the main stressor that the animals have to face during the deprivation process. In this study, we analyzed the effects of short-term (24 h) and long-term (240 h) REM sleep deprivation on the distribution of lymphocyte subsets in the peripheral blood of rats. In addition, these effects were compared with those obtained after both short- and long-term stress by immobilization.

METHODS

Lymphocyte population bearing surface markers such as CD5 (T cells), CD45RA (B cells), CD4 (T helper/inducer cells), CD8 (T suppressor/cytotoxic cells) and CD161 (NK cells) were analyzed using monoclonal antibodies. Lymphocyte subsets were assessed by flow cytometry.

RESULTS

Both short- and long-term REM sleep deprivation decreased the percentage of T lymphocytes and induced a significant increase in NK cells. Short-term immobilization induced only a significant increase in the percentage of B lymphocytes and a decrease in the percentage of T lymphocytes, while long-term immobilization did not elicit any change.

CONCLUSION

The present results support the notion that REM sleep deprivation and immobilization stress each exert particular effects on the immune system. These data suggest that the characteristics of the immune response will depend on the nature of the behavioral manipulation.

Corticosterone and testosterone levels after chronic stress in an animal model of depression

Neonatal administration of clomipramine (CMI) in rats induces behavioral changes during adulthood, such as impairments of pleasure-seeking behaviors. However, the endocrine changes induced by this treatment are controversial. In the present study, we analyzed the levels of corticosterone and testosterone in rats neonatally treated with CMI in response to chronic stress by repeated immersion in cold water. Results obtained in the forced swim test corroborated the effect of neonatal CMI administration, showing a significant increase in immobility time. The testosterone response to stress was similar in both control and CMI-treated rats. Concerning corticosterone, there was a significantly lower response to stress in CMI-treated rats. The data suggest that CMI induces permanent changes in the reactivity of the hypothalamic-pituitary-adrenal axis, without affecting the hypothalamic-pituitary-gonadal axis.

Copulatory activity increases slow-wave sleep in the male rat

It is believed that sexual activity increases the need to sleep in many species. However, the relationship between copulatory activity and sleep has been poorly studied. Several studies have observed variations in the sleep of female rats and women as a function of their reproductive state. These effects have been correlated with the effects of female steroid hormones, but not with sexual activity. The aim of the present study was to evaluate the sleep-wake pattern of male rats immediately after different conditions of copulatory activity. Sexually experienced male rats were chronically implanted with a standard set of electrodes for sleep recording. After a control sleep recording of 8 h, the males were randomly assigned to one of the following experimental conditions: 30 min in the presence of an ovariectomized (OVX) rat; 30 min in the presence of an intact non-receptive female (NRF); with a receptive female until reaching one ejaculation (1E); and with a receptive female until reaching three ejaculations (3E). In addition, after 10 days, males were randomly exposed to one of the following copulatory conditions during 4 h: to remain in the presence of an OVX rat; to remain in the presence of an NRF female, and with receptive females until reaching sexual satiety (SS). Male sexual behavior was assessed just after the onset of the dark period, and sleep recordings were obtained during 8 h immediately after experimental testing. Both the three ejaculations group (3E) in the first experiment and the sexual satiety group (SS) in the second experiment showed enhanced percentages of time spent in slow wave sleep (SWS) II and a shorter latency to the first SWS II episode than in the control group or under basal conditions. In addition, neither the presence of a non-receptive female or an OVX female, nor sexual behavior until reaching one ejaculation induced any effect on the sleep stages. These findings suggest that the increase in SWS II induced by both 3E and SS may be governed by some specific mechanism that is essentially independent of physical exercise or stress. Copulatory activity might be the source of neurohormonal processes that induce sleep and may involve the participation of gamma-aminobutyric acid, serotonin or other endogenous regulators of sleep and wakefulness. Nevertheless, the precise mechanism by which the sexual behavior increases SWS is still to be determined.

Pharmacological features of masculine sexual behavior in an animal model of depression

Neonatal treatment with clomipramine induces behavioral alterations during adulthood that resemble symptoms observed in human depression. Therefore, it has been proposed as an animal model of depression. Impairment of male sexual performance is one of the main effects of this treatment. Using this model of depression, we evaluated the effects of drugs that stimulate sexual performance by acting selectively on the adrenergic, serotonergic, or cholinergic system. Yohimbine, a selective antagonist of the alpha-2 receptors; 8-OH-DPAT, a selective agonist of the 5-HT1A receptors; and oxotremorine, a muscarinic agonist, were administered to male rats neonatally treated with clomipramine that showed sexual behavior impairments. Yohimbine and oxotremorine induced only a slight improvement of sexual deficiencies. 8-OH-DPAT not only restored sexual behavior to normal levels, but induced facilitation in most of the copulatory parameters. These results suggest that neonatal treatment with clomipramine induces sexual deficits acting mainly on the adrenergic and cholinergic systems, while the serotoninergic system seems to be preserved.

Lack of effect of corticosterone administration on male sexual behavior of rats

The increase in plasma levels of corticosteroids as part of the stress response has been associated with failure in the reproductive function in most vertebrate species, both in females and males. Recently, we have shown that male sexual performance in rats is readily affected by different stressors, both acutely and chronically applied. However, there are few reports that directly correlate the increase in corticosteroid levels with the behavioral effects of stress. In this study we investigated whether the administration of corticosterone, either acutely or chronically, could reproduce the effects of stress on male sexual behavior in the male rat. Four doses of corticosterone (0.5, 1, 2, and 4 mg) or the vehicle, were administered during four consecutive days to sexually experienced males. Male sexual behavior was assessed after the first and the fourth injection. After the last test, males were killed and levels of corticosterone and testosterone were measured by HPLC. We observed an increase in corticosterone plasma levels in a dose-dependent manner. None of the sexual behavior parameters, however, was modified. Plasma levels of testosterone were not modified by corticosterone administration. Both steroids were increased in response to sexual activity, though. These data show that, unlike amphibians and female mammals, corticosteroids do not alter sexual behavior in male rats and suggest that the effect of stress on male sexual behavior cannot be explained by increases in corticosterone.

Cholinergic-androgenic interaction in the regulation of male sexual behavior in rats

It is well known that testosterone (T) plays a major role in the adequate expression of male sexual behavior. On the other hand, the stimulation of central muscarinic receptors with oxotremorine (OXO), a specific agonist, facilitates the expression of masculine sexual behavior in rats. In this study, we analyzed the relationship between T and the cholinergic system, recording the effect of OXO administration on masculine sexual behavior in gonadectomized rats, before and after receiving T treatment. Sexually experienced and unexperienced male rats were gonadectomized and periodically tested for sexual behavior. Once this behavior was absent or drastically reduced, males were treated with OXO or saline and sexual behavior was assessed. 112 or 167 days later, animals were treated daily with T during 21 days, recording the response to OXO in days 12 and 21. Sexual behavior decreased more rapidly after gonadectomy in inexperienced males. OXO administration did not improve sexual performance in either group. The administration of T rapidly restored sexual behavior of experienced males: recovery of inexperienced males was slower. In the presence of T, OXO administration exerted a facilitative effect on sexual performance of both groups. These results suggest that the facilitative effect of muscarinic stimulation on sexual behavior requires the presence of testosterone.

Effects of short- and long-term REM sleep deprivation on sexual behavior in male rats

The influence of selective REM sleep deprivation on masculine sexual behavior has been a matter of controversy. In the present study, the sexual behavior of male rats was analyzed in subjects deprived on REM sleep by the island technique for 24 or 16 h daily during 20 days. When compared to control rats, both groups displayed changes in sexual performance since the first day. The effects were: an increase in mount, intromission and ejaculation latencies and in mount frequency as well; a decrease of ejaculation frequency and of the Hit rate. The effects became stronger as REM sleep deprivation progressed. Rats deprived of REM sleep for 24 h were extremely debilitated after 12 days and some of them died, whereas the rats REM deprived for 16 h remained healthy during the 20 days. These data indicate that REM sleep deprivation interferes with the mechanisms that regulate male sexual behavior.

Effect of acute and chronic stress on masculine sexual behavior in the rat

Masculine sexual behavior in rats can be stimulated by acutely stressing the animals. Nevertheless, little is known about the effect that different stressors could have on sexual behavior. In this work we studied the effect of different stressors applied both acutely and chronically on masculine sexual behavior. Sexually active male Wistar rats were submitted to stress by: immobilization (IMB); immersion in cold water (WIM); and electrical foot shock (EFS). These stressors were applied during 20 consecutive days and masculine sexual behavior was assessed on days 1, 4, 8, 12, 15 and 20. Motivational component, copulatory performance and copulatory potential were drastically altered by WIM. EFS produced significant alterations in almost all sexual parameters recorded but only when it was applied chronically. IMB only altered mount frequency and hit rate, although inconsistently. These results suggest that the effect of stress on sexual behavior depends on the nature and, in some conditions, on the duration of the stressor.

Evidence that the M1 muscarinic receptor subtype mediates the effects of oxotremorine on masculine sexual behavior

The cholinergic system participates in the regulation of masculine sexual behavior, mainly through the muscarinic system. Recently, muscarinic receptors have been subdivided into at least two subtypes, M1 and M2, according to their differential affinity for pirenzepine. In this study, we analyzed the possible participation of the M1 muscarinic receptor subtype on masculine sexual behavior regulation. In the first experiment, trihexyphenidyl, a specific M1 antagonist, was administered to experienced adult male rats in a wide range of doses (from 0.1 to 6.4 mg/kg). No modification was observed in any of the male sexual behavior parameters recorded, with the exception of the highest dose at which an increase of the intromission frequency and a decrease of the ejaculation frequency were observed. In the second experiment, trihexyphenidyl was administered in several doses (from 0.2 to 1.6 mg/kg), before the administration of oxotremorine, a muscarinic agonist, at a dose that readily facilitates masculine sexual behavior. Trihexyphenidyl completely prevented the facilitatory effects of oxotremorine even at the smallest dose used. These results strongly suggest that the M1 muscarinic receptor subtype participates in the cholinergic facilitation of masculine sexual behavior.

Muscarinic and nicotinic influences on masculine sexual behavior in rats: effects of oxotremorine, scopolamine, and nicotine

In this study, the role of cholinergic systems in the regulation of male sexual behavior was analyzed by different approaches. Both muscarinic agonists and antagonists, as well as a nicotine agonist, were administered to sexually experienced male rats. In Experiment 1, oxotremorine (OXO), a muscarinic agonist, decreased the intromission frequency and ejaculatory latency in a dose-dependent way. Moreover, an increase in ejaculatory frequency was observed. In Experiment 2, the muscarinic antagonist scopolamine (SCO) produced a dose-related impairment of sexual behavior, decreasing the percentage of sexually active males. The smaller doses of SCO delayed the initiation of sexual behavior and decreased ejaculatory frequency. In an attempt to analyze the effect of muscarinic supersensitivity on sexual behavior, in Experiment 3 a long-term blockade of muscarinic receptors (SCO for 17 days) was followed by OXO administration. Animals displayed a significant increase of mount frequency, which results in the decrease of both the hit rate and ejaculatory frequency. In Experiment 4, six doses of nicotine were acutely administered. Only the higher doses (0.4, 0.8, and 1.6 mg/kg) induced a decrease in intromission frequency, although no significant differences were found in any other parameter. These results strongly suggest that cholinergic participation in masculine sexual behavior regulation is mediated mainly through muscarinic system.